About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Role of Activin A (ActA) in the Human Cancer Cachexia

NCT01604642·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

18-year-old or older
Colorectal or lung cancer demonstrated by histology or cytology
New diagnosis or new recurrence
Expected survival more than 3 months
No previous history of other cancer in the last 5 years
No pregnancy or lactation
Signed informed consent

You may not be if

Non-caucasian
Major digestive malabsorption
Major depression
Artificial nutrition
Height doses of steroids (\>1 mg/kg hydrocortisone equivalent)
Hyperthyroidism
Other causes of malnutrition
Expected survival less than 3 months
Severely impaired walking
Anticoagulants or antiplatelet therapy
Disability or medical condition which might prevent the compliance to the protocol
Any conditions which may prevent the compliance to the protocol
Performance status ECOG \> ou = 4
Participation to other clinical studies

The record

StatusCompleted

PhaseNo phase

Taking part150

StartedMay 2012

UpdatedApr 2, 2018

Conditions

Colorectal Cancer Lung Cancer

Where1

Cliniques Universitaires Saint-Luc
Brussels, Belgium

Clareo Health | Role of Activin A (ActA) in the Human Cancer Cachexia